Advancing Colorectal Cancer Research with Biomarker-Driven Tools
As colorectal cancer research continues to shift toward precision approaches, the ability to accurately detect and characterize key biomarkers is more important than ever.
Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
As colorectal cancer research continues to shift toward precision approaches, the ability to accurately detect and characterize key biomarkers is more important than ever.
Alzheimer’s Disease is complex disease on the rise worldwide. Glycosylation is critical to every facet of disease mechanisms and treatments.
Join us at booth #21 to explore solutions across spatial analysis, single cell proteomics, and biomarker discovery. This year, Vector Labs is highlighting new approaches to protein glycosylation and spatial biology, alongside our broader portfolio... Read more
Vector has been highly commended for the 2026 CiteAb Innovation Award, recognizing the impact of the Glysite Explorer in advancing glycosylation research.
Glycosylation is an understudied but critical component of colon carcinoma. The right tools aid in cancer research, diagnosis, and treatment.
Protein glycosylation is ubiquitous yet overlooked. Learn how Vector's suite of tools bring protein glycosylation insights to researchers across fields.
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
NEWARK, Calif.July 15, 2025 The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression. Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and Navinci,... Read more